Filariasis : Introduction, Symptoms, Causes, Diagnosis, Management and Prevention - www.genericdrugscan.com

Filariasis : Information

Filariasis is caused by several round, coiled and thread-like parasitic worms that belongs to the family filaridea. These parasites penetrate the skin either their own or through the opening created by mosquito bites to reach the lymphatic system. The disease is caused by the nematode worm, either Wuchereria bancrofti or Brugia malayi and is transmitted by mosquito species Culex quinquefasciatus and Mansonia annulifera/M.uniformis respectively. The disease generally presents with the symptoms like swelling of legs, and hydrocele and can cause a raft of societal stigma. Lymphatic Filariasis (LF)is commonly known as elephantiasis. It is a disfiguring and disabling disease, which is generally aquired in childhood. In the early stages,though there are either no symptoms or non-specific symptoms, the lymphatic system is damaged. This stage can last for several years. Infected persons sustain the transmission of the disease. The long term physical consequences are painful swollen limbs (lymphoedemaor elephantiasis). Hydrocele in males is also common in endemic areas. National Vector Borne Disease Control Programme

• Filariasis control in India and Its Elimination

Lymphatic filariasis infection involves asymptomatic, acute, and chronic conditions. The majority of infections are asymptomatic, showing no external signs of infection, although their blood is positive for microfilaria. This stage may lasts for months. Acute episodes of local inflammation involving skin, lymph nodes and lymphatic vessels. Chronic condition shows oedema with thickening of the skin and underlying tissues (the classical symptom of filarasis). It usually affects the lower extremities. However, the arms, vulva, breasts and scrotum (causing hydrocele formation) can also be affected.The oedema in the extremities, breast or genital area can result in the part becoming several times its normal size and is due to blockage of the vessels of the lymphatic system.
References:
www.cdc.gov
www.who.int

Most cases of filariasis are caused by the parasite known as Wuchereria bancrofti. Culex, Aedes and Anopheles mosquitoes serve as vector for W.bancrofti in transmission of the disease. Another parasite called Brugia malayi also causes filariasis is transmitted by the vector Mansonia and Anopheles mosquitoes. When an infected mosquito bites a healthy person, the larvae called microfilariae move into the lymphatics and lymph nodes. Here, they develop into adult worms and may persist for years. The adult parasite, in turn, produces more microfilariae. These microfilariae circulate in the peripheral blood usually in the night, and are sucked by the mosquitoes during a bite. The same cycle is then repeated in another healthy individual. Reference: www.cdc.gov

Blood sample: The microfilariae that cause lymphatic filariasis circulate in the blood at night (called nocturnal periodicity). Blood collection should be done at night to coincide with the appearance of the microfilariae, and a thick smear should be made and stained with Giemsa or hematoxylin and eosin. For increased sensitivity, concentration techniques can be used. Serological examination: Serologic techniques provide an alternative to microscopic detection of microfilariae for the diagnosis of lymphatic filariasis. Patients with active filarial infection typically have elevated levels of antifilarial IgG4 in the blood and these can be detected using routine assays. For further diagnosis, consult your physician. Reference: www.cdc.gov

Maintenance of Good hygiene of the affected part prevents the worsening of the lymphoedema and secondary bacterial skin infections. The affected limb should be kept elevated and regular exercises should be done to improve the lymph flow. The recommended regimen for treatment of filariasis is mass drug administration (MDA) in which a single dose of two medicines are given together - albendazole (400 mg) with either ivermectin (150-200 mcg/kg) in areas where onchocerciasis (river blindness) is also endemic or diethylcarbamazine citrate (DEC) (6 mg/kg ) in areas where onchocerciasis is not endemic. These medicines clear microfilariae from the bloodstream. Though Lymphatic filariasis is treated with medicines, there is persistent abnormal enlargement of body parts causing pain and severe disability. Associated social stigma makes patients to suffer mentally, socially and financially. Elimination of lymphatic filariasis is possible by stopping the spread of infection with mass drug administration (MDA) and protection from mosquito bites and vector control measures. For more queries you should consult your doctor.
References:
www.who.int
www.cdc.gov